TELA Bio Reports First Quarter 2025 Financial Results


MALVERN, Pa., May 08, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today reported financial results for the first quarter ended March 31, 2025.

Originally posted here:
TELA Bio Reports First Quarter 2025 Financial Results

Related Posts